Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Cellular stress and macrophage activation235
Exploiting antifungal immunity in the clinical context179
Editorial Board92
Differential immune responses behind different celiac disease manifestations78
Three’s company: The cooperative signals behind the differentiation of Th9 cells72
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity71
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity68
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells68
Editorial Board62
Pyroptosis modulation by bacterial effector proteins60
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges58
Local and Cell-intrinsic complement: The new player in cancer progression56
Resolving inflammatory links between myocardial infarction and vascular dementia55
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi54
Aging of lymphoid stromal architecture impacts immune responses54
Microbial metabolites and immunotherapy: Basic rationale and clinical indications52
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity50
Immunity to pathogenic fungi in the eye48
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?46
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)45
Pyroptosis: A road to next-generation cancer immunotherapy44
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease44
Pyroptosis and the cellular consequences of gasdermin pores38
The noncanonical inflammasome-induced pyroptosis and septic shock36
Interplay between the complement system and other immune pathways in the tumor microenvironment35
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity35
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment35
Western diet influences on microbiome and carcinogenesis34
The evolving biology of cross-presentation33
Immunity to fungi: Editorial overview33
Autoimmune diabetes and targets for immunomodulation31
Neuroimmune interactions between itch neurons and skin microbes30
Adaptive NK cell response to human cytomegalovirus: Facts and open issues29
Interleukin-1β and cancer immune response29
The paradox of aging: Aging-related shifts in T cell function and metabolism29
TREM2: A new player in the tumor microenvironment28
Specialized pro-resolving mediators as modulators of immune responses27
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases26
Recent developments in C3-targeted complement therapeutics25
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy24
Sialic acid and Siglec receptors in tumor immunity and immunotherapy24
Antigen discovery for the development of cancer immunotherapy24
Thymus aging and immune reconstitution, progresses and challenges24
Introduction to the Special Issue: Nutrition, microbiota and immunity23
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases23
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic22
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination22
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs22
T cell control of SARS-CoV-2: When, which, and where?22
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?22
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy21
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity21
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders21
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity20
The glycoimmune landscape in health and disease20
Targeting the tissue-complosome for curbing inflammatory disease20
Editorial Board20
T cell fate decisions during memory cell generation with aging20
Publisher's note: Welcome Prof. Guido Kroemer19
Natural killer cell responses to human oncogenic γ-herpesvirus infections19
The complement system in clinical oncology: Applications, limitations and challenges18
Proteostasis in T cell aging18
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis17
Identification of T cell antigens in the 21st century, as difficult as ever17
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy17
Global aspects of celiac disease and food allergy17
Emerging opportunities for C3 inhibition in the eye17
Better safe than sorry: Naive T-cell dynamics in healthy ageing17
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging17
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions17
Harnessing complement biomarkers for precision cancer care16
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review16
Human thymus in health and disease: Recent advances in diagnosis and biology16
Epigenetic and transcriptional control of gasdermins16
The multisensory regulation of unconventional T cell homeostasis16
Unconventional protein secretion by gasdermin pores15
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]15
A major mechanism for immunomodulation: Dietary fibres and acid metabolites15
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation15
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches15
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics15
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond15
Microbial gasdermins: More than a billion years of pyroptotic-like cell death14
Siglecs as modulators of macrophage phenotype and function14
The role of ILC subsets in cancer14
Durability of immune responses to SARS-CoV-2 infection and vaccination14
Systems analysis of innate and adaptive immunity in Long COVID14
Pyroptosis-induced inflammation and tissue damage13
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC13
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases13
Reparative inflammation in multiple sclerosis12
Editorial Board12
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data12
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas12
Galectins and Host–Pathogen Interactions: The roles in viral infections12
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease12
Integrating immunopeptidome analysis for the design and development of cancer vaccines12
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond12
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function11
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation11
The gut-brain vascular axis in neuroinflammation11
Systems analysis of human innate immunity in COVID-1911
Complement regulation in tumor immune evasion11
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies11
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives11
Regulatory T cells in allergic inflammation11
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions11
Publisher’s Note: A change in leadership11
To die or not to die: Gasdermins in intestinal health and disease10
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences10
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions10
Complement component C3: A structural perspective and potential therapeutic implications10
The role of sialoglycans in modulating dendritic cell function and tumour immunity10
Editorial Board10
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging10
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging10
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies10
Immunity to fungi in the lung10
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus10
0.092751979827881